N 1998, an estimated 1.2 million new cancer cases will be diagnosed. 24 In North America, approximately 18,000 new cases of metastasis to the spine are diagnosed each year. 42 For example, from 1984For example, from to 1994 new patients were referred to The University of Texas M. D. Anderson Cancer Center (M. D. Anderson) for treatment of various neoplasms (Table 1) . Metastatic disease was found in the spinal columns of 11,884 of these patients. Such patients often require urgent treatment to alleviate the intractable pain the tumors cause and to address spinal cord compromise resulting from direct compression by tumor, retropulsion of vertebral fragments, or severe kyphosis. Medical care of these patients is expensive, and costs may be increased if the tumor produces paresis or paraplegia.
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I pain is constant and generally does not worsen with movement or improve with recumbency. Imaging studies in patients with local pain usually reveal enlargement of the vertebral body without evidence of vertebral body collapse or spinal deformity. The cause of this pain has been attributed to periosteal stretching of the vertebral body by the tumor mass.
Axial spinal pain is a significant cause of morbidity. It is a mechanical pain resulting from a structural abnormality in the spinal column. This type of pain worsens with movement and is relieved with recumbency. Imaging studies performed in patients having axial pain usually reveal vertebral body collapse and/or spinal deformity. Spinal stabilization is normally very effective in relieving this type of pain. Radiation therapy is of no benefit in alleviating discomfort in patients with axial pain.
Radicular pain is related to compression of a nerve root. It is usually constant, but may be worsened or relieved with movement. The pain occurs in a dermatomal distribution and is usually associated with dysesthesia. Depending on the cause of the compression, the nerve root may need to be decompressed either surgically, to remove pressure from a bone fragment or tumor mass, or with the use of chemotherapy and/or radiation treatment, in the case of chemosensitive or radiosensitive tumors.
During the last few years we have implemented an aggressive, multidisciplinary surgical approach to neoplasms found at all spinal levels, both for intervention in patients with confirmed or impending neurological compromise from spinal cord compression and for palliation of severe, intractable pain that is difficult to alleviate, even with narcotic analgesic medications. The anterior (transthoracic) approach provides the most direct route to the spinal column for decompression, reconstruction, and stabilization, and is now the method we prefer for resecting tumors largely confined to thoracic vertebral bodies. Among its other advantages relative to posterior approaches, the anterior approach permits minimal removal of uninvolved bone, rapid removal of tumor, effective reconstruction of the weight-bearing anterior column, short-segment fixation, and improved wound healing. The purpose of this study was to describe our surgical procedure and its results with respect to pain relief, neurological recovery, and risk of complications in patients with metastatic tumors who underwent transthoracic vertebrectomy via a sternotomy, thoracotomy, or thoracoabdominal approach.
Clinical Material and Methods

Patient Population
We performed 523 spinal operations on 400 patients with cancer from February 1, 1994 through July 31, 1997 at M. D. Anderson. Seventy-two patients with metastatic disease involving the thoracic spine underwent vertebrectomies via the transthoracic approach and represent the study population of this paper. Certain characteristics of 47 of these patients have already been published. 42 Indications for surgery were symptomatic spinal cord compression and/or intractable axial spinal pain resulting from spinal instability. All patients had an estimated life expectancy that exceeded 3 months.
The patients' records were retrospectively reviewed, and data were collected on patient age, gender, date of initial diagnosis, histological characteristics of the primary tumor, and date of onset of symptoms referable to spinal disease. Medical treatment (chemotherapy, radiation therapy, or both) prior to the surgical consultation was recorded, in addition to the number of extraspinal metastases at the time of the patients' spinal surgery. The following surgical data were obtained: use of preoperative tumor embolization, intraoperative blood loss, method of spinal stabilization, postoperative complications (within 1 month), number of days chest tubes were required, and length of postoperative hospital stay. Postoperatively, patients were evaluated at 1 month and thereafter at 3-month intervals for the 1st year. Subsequently, they were evaluated every 6 months. Plain x-ray films (anteroposterior and lateral) were obtained at each visit. Patients underwent spinal magnetic resonance (MR) imaging every 3 to 6 months as part of their systemic workup.
Postoperative pain and neurological status were evaluated at each patient's 1-month follow-up visit because this was long enough for incisional pain to resolve but short enough for an assessment of pain and narcotic usage to reflect only the effects of the recent operation. (In other words, at this point patients were unlikely to have acquired other metastases in the spine or at distant sites that might have clouded the picture.) We used visual analog pain scales and recorded narcotic analgesic medication usage before and after surgery to assess pain response. Postoperative pain was graded as "worse," "no change," "improved," or "complete resolution" based on the patient's pain rating. Additionally, the type of pain medication used both pre-and postoperatively was classified as shown in Table 2 . The Frankel scale 13 was used for pre-and postoperative assessment of each patient's neurological status, including motor, sensory, and autonomic function ( Table 3) . Each patient's pain rating, use of analgesic medications, and neurological function were recorded immediately prior to surgery and at the 1-month fol- Interventional radiologists performed tumor embolization 18 to 24 hours before surgery, when appropriate, as determined by the tumor's histological characteristics and vascularity. This was generally performed in patients with renal cell carcinoma and, occasionally, in those with other vascular metastatic tumors. All patients received standard perioperative antibiotic agents and subcutaneous heparin for deep vein thrombosis prophylaxis.
In the case of lesions located at T-1 or T-2, we performed a combined sternotomy and anterior neck dissection ( Figs. 1 and 2) . The favored entry site was the left side of the neck, because approaching the spine from the patient's right side increases the risk of stretch injury to the right recurrent laryngeal nerve.
For exposure of the high thoracic region involving T-3 and T-4, the "trap door" approach was used. This approach combines a standard anterior neck dissection with both a partial median sternotomy and an anterolateral thoracotomy.
For lesions involving T5-10, posterolateral thoracotomy was performed after placement of a single-lumen endotracheal tube. Here, the right hemithorax was the preferred site of entry; however, tumors with a large extravertebral extension were approached on the side having the bulk of tumor. In patients who have had previous chest operations, we prefer an approach via the contralateral hemithorax to avoid problems with prolonged postoperative air leaks that would require an extended duration of chest tube placement and could increase the risk of contaminating the spinal hardware. For lesions involving T-5 and T-6, the fifth rib was removed. For T-7 and T-8, the rib located one level above the tumor epicenter (6th or 7th, respectively) was removed. For T9-11 tumor involvement, the rib two levels above (seventh, eighth, or ninth rib, respectively) was removed. The thoracoabdominal approach was chosen for treating metastatic lesions occurring in T-11 and T-12.
Surgical resection began immediately in cases in which the tumor was grossly visible within the chest cavity; however, when the identity of the vertebral lesion was in doubt, an intraoperative x-ray film was obtained by using a localizing spinal needle to confirm the spinal level. The parietal pleura overlying the area of interest was incised and reflected ventrally. We identified the segmental vessels at the vertebrectomy site and at the levels above and below it. These vessels were doubly ligated and transected. We performed discectomies rostral and caudal to the vertebrectomy site using a No. 15 blade scalpel, pituitary rongeurs, and curettes. Leksell rongeurs were used to begin removal of the vertebral body; we then switched to a high-speed power drill with diamond or cutting burr attachments until we reached the posterior longitudinal ligament, which was incised and dissected away from the dural sac. We always opened the posterior longitudinal ligament and visualized the nerve roots exiting at the level of the resection to ensure complete decompression of the thecal sac. In situations in which the tumor was too solid for aspiration by ordinary suction devices but was too soft for the high-speed drill, we used an ultrasonic aspirator A T-1 vertebrectomy, anterior reconstruction with methylmethacrylate, and plating were performed via an anterior cervical approach combined with a sternotomy.
(Cavitron Ultrasonic Aspirator; ValleyLab, Inc., Boulder, CO). When resecting was finished, we fully visualized the end plates of the vertebral bodies above and below the level of resection and determined them to be free of disc material and gross tumor ( Fig. 3-1 ).
Following the vertebrectomy, we used a right-angled drill attachment to create a cylindrical central defect in the vertebrae above and below the resection site that extended into the bone a distance equaling 75% of the height of each vertebra, as described by Errico and Cooper. 12 We preserved a portion of each vertebra and the remaining endplate to maintain the structural integrity of the bone and to provide anchorage for fixation screws. A No. 36 French chest tube was shortened to a length equaling the total height of the space created by the vertebrectomy defect plus the length of the holes drilled above and below ( Fig. 3-2 ). We cut a hole in the center of this tube for injection of methylmethacrylate and made additional holes at each end of the tube to permit air to escape during injection of the cement. The tube was positioned so that it spanned the vertebrectomy defect ( Fig. 3-3 ). We were careful to prevent contact between the cement and the thecal sac during injection and solidification ( Fig. 3 -4-5) because heat released during the polymerization reaction can injure the cord and expansion of the acrylic cement can compress it. We irrigated the construct with tepid saline during this step to minimize the heat released to surrounding tissues.
Thoracolumbar locking plate and screw constructs were used to provide additional anterior spinal stabilization to prevent distraction failure with all vertebrectomies below T-6 ( Fig. 3-6 ). For fixation of lesions above T-6, a cervical locking plate and screw construct was used (Synthes USA, Paoli, PA; Fig. 2 ). In seven patients (10%) in whom severe kyphosis was present ( Fig. 4 ) or in whom the metastasis resided in a junctional (cervicothoracic or thoracolumbar) zone, posterior hooks, rods, pedicle screws, or wires were used as needed ( Fig. 5 ). External orthoses were not used in any patient.
We placed one or two chest tubes (No. 32 or 36 French) in the thoracic cavity and used a standard procedure for chest closure. The chest tubes were not removed until the drainage for a 24-hour period was less than 150 to 200 ml.
Results
Seventy-two patients underwent surgery via an anterior approach for metastatic disease involving the thoracic spine between February 1, 1994 and July 31, 1997. Among the 24 women and 48 men, the median age was 56 years (range 19-78 years). Forty-six (64%) of these patients suffered from weakness in the lower extremities, and 65 (90%) of 72 reported pain, either local or radicular pain with no spinal instability (23 patients), or axial spinal pain resulting from spinal instability (42 patients). Twenty-two patients who had no previous history of cancer presented initially with pain only. In the remaining 50 patients with a known history of cancer, the median time to symptomatic presentation from primary tumor discovery was 19 months (range 0-15 years).
Primary tumors in the study group included: renal cell carcinoma in 19 patients, breast cancer in 10, melanoma or sarcoma in 10, lung cancer in nine, head and neck cancer in six, prostate cancer in two, and multiple myeloma in two patients; the primary tumors in the remaining 14 patients fell into other categories. These patients were recognized as having an average of 2.5 extraspinal sites of metastatic cancer (range 0-15) at the time of their spinal surgery.
Prior to surgical consultation, an initial attempt was made to treat the spinal disease medically in 53 patients: 10 were treated with chemotherapy alone, 10 received radiation therapy alone, and 33 patients were treated with both chemotherapy and radiation therapy before surgery (Table 4 ). Twelve patients underwent preoperative tumor embolization (10 with renal cell carcinomas, one with a hemangiopericytoma, and one with a thyroid carcinoma metastasis). The remaining 19 patients were referred directly to surgery by the medical or radiation oncologist, and no other treatment modalities for the spinal disease were attempted before surgery.
Transthoracic approaches varied according to spinal level. Six patients with lesions at T1-2 underwent sternotomy; two with T3-4 tumors were approached via a "trap door" exposure; 47 patients with T5-10 involvement were treated with a posterolateral thoracotomy; and 17 with T11-12 lesions underwent a thoracoabdominal approach. Forty-five patients underwent single-level vertebrectomies, 21 required two-level vertebrectomies, and six underwent vertebrectomies at three contiguous levels.
Total blood loss ranged from 100 ml to 31 L (median 850 ml). In the entire study population, the median blood loss per level surgically treated was 700 ml (range 50-15,500 ml). In the case of patients with renal cell disease, the median blood loss per level showed more than a twofold increase (median 1750 ml; range 300-15,500 ml).
We customarily admitted patients to our surgical intensive care unit immediately after surgery. Thirty-five patients were extubated on the day of surgery in either the operating room or recovery room. The median chest tube requirement was 4 days (range 1-26 days). Within 24 hours of chest tube removal, patients were either discharged or moved to our in-hospital rehabilitation unit if they needed extended physiotherapy. Postoperative hospital stays ranged from 4 to 55 days (median 10 days).
We observed a total of 24 surgically related complications (14 major and 10 minor) in 21 patients. Major com-plications included epidural hematoma in three patients, pneumonia in three, gastrointestinal bleeding in two, cerebrospinal fluid leak in two, renal failure in two, cecal perforation in one patient, and pulmonary embolism in one patient. Minor complications included atelectasis, ileus, atrial fibrillation, pleural effusion, and superficial wound infection, each of which was observed in two patients. These complications resulted in the only two deaths recorded in the study, giving an overall 30-day mortality rate of two (3%) of 72. One death resulted from a spontaneous cecal perforation with sepsis in a patient with multiple myeloma who was receiving high-dose steroid medication, and one occurred in a patient who died of respirato-ry failure following T-7 and T-12 vertebrectomies for metastatic lung cancer.
Three patients experienced a decrease in neurological function following embolization of their spinal metastases prior to surgical resection. One patient experienced transient worsening in function, but the other two patients sustained permanent deficits (one changed from Frankel E to Cb and the other from Frankel E to D1a). Three patients experienced postoperative deterioration in neurological function. Imaging studies in these patients suggested the presence of epidural hematomas; however, at subsequent reoperation, only one patient was found to have a signifi- remained neurologically worse, whereas the other two patients returned to their original preoperative neurological status; thus, the permanent neurological complication rate in our series was one (1.4%) of 72 patients. There were no instrument-or graft-related complications. Recurrence requiring reoperation occurred in six patients at the original surgical site and in two patients at a distant site.
The overall 1-year survival rate was 62% ( Fig. 6 upper, Kaplan-Meier estimate). Figure 6 lower illustrates Kaplan-Meier curves for the four most commonly encountered tumors. The 1-year survival rates for renal cell, breast, and lung cancer were 65%, 63%, and 55%, respectively, and that for melanoma or sarcoma was 52%. The mean duration of follow up was 11 months, with an 88% level of follow up achieved at 6 months and 84% at 1 year. Nineteen patients were followed for more than 2 years with no evidence of hardware loosening or impending failure.
Of the 65 patients who presented with pain as a result of spinal metastasis (Fig. 7) , complete resolution was achieved in 15 (23%); pain was significantly improved by the operation in 45 (69%) and unchanged or worsened in five (8%). Thus, 60 (92%) of 65 patients showed completely or greatly reduced pain postoperatively (p Ͻ 0.001, Wilcoxon signed-rank test). Pain control at the operative site was durable (except in patients who had recurrence and underwent a second operation).
To substantiate the patients' perception of pain relief, we analyzed their use of pain medication (Fig. 8 ). Detailed documentation of pain medication use was available in 61 of the 65 patients who presented with pain. The two patients who died postoperatively were not included, nor were two patients whose documentation did not adequately specify the type of medication they were taking. Analgesic medication usage was significantly reduced postoperatively (p Ͻ 0.001, Wilcoxon signed-rank test). Twenty-eight patients were able to decrease their class of pain medication by at least one category. Seventeen patients required no pain medication postoperatively, including three patients who had required intravenous or transdermal narcotics preoperatively. Twenty-nine patients showed no change in their medication category following the procedure, whereas four patients required an increase in their class of medication.
Despite the high degree of pain relief achieved in our series, a large proportion of patients were still using narcotic pain medications at the time of their 1-month followup appointment. Of the 23 patients requiring pain medication from either Category 4 or 5 postoperatively ( Fig. 8 ), five patients claimed to have greatly improved spinal column pain but required the pain medication for other bone metastases. Four patients required this type of pain medication for incisional or "thoracotomy" pain 1 month following the procedure, despite improvement in their spinal column pain. If we eliminate these nine patients, we are left with 14 patients who required strong narcotic analgesics postoperatively for pain related to their spinal column disease. Six of these patients had required intravenous narcotics, preoperatively, and their pain was managed well after surgery with oral narcotic medications. Seven patients continued to take the same type of analgesic, but they reported improved pain relief. The remaining patient who required strong narcotic medications following surgery reported no improvement in her pain management.
With the exception of the three patients who experienced complications related to embolization, 46 (67%) of 69 patients presented with neurological dysfunction. Thirty-five (76%) of these 46 neurologically impaired patients improved neurologically after surgery (p Ͻ 0.001), with 27 patients improving at least one Frankel grade and 20 patients regaining normal neurological function ( Fig.  9 ). Preoperatively, of these 46 neurologically impaired patients 33 were ambulatory but had weakness, and 13 were nonambulatory. Following surgery, 17 (52%) of the 33 patients who had been ambulatory with weakness regained normal strength and 15 (45%) remained ambulatory with weakness. One patient who developed a postoperative hematoma and had presented with profound weakness was unable to walk postoperatively (changed from Frankel D2b to Ca) despite evacuation of the hematoma. Of the 13 preoperatively nonambulatory patients, 10 regained ambulatory ability after surgery (three of these patients regained normal neurological function). The remaining three of the 13 patients remained nonambulatory following the operation.
Discussion
In the present study we attempt to provide a clear perspective of results that can be expected of anterior verte-bral body resection and stabilization for spinal metastases that are limited to the thoracic region ( Fig. 10) . Previously published reports of major studies in which the anterior approach was used to remove spinal lesions from a large patient complement have included tumors located in other spinal regions. 20, 35, 39, 40 This study is based on a patient population that was uniform in tumor location (thoracic) and tumor type (metastatic). A uniform surgical approach (transthoracic) was used in all patients, and all of them underwent reconstruction with methylmethacrylate and stabilization with anterior plating. We only included patients with thoracic spinal metastases and excluded those with paravertebral spinal lesions because spinal involvement by direct extension of tumors such as lung carcinomas and/or soft tissue sarcomas is likely to be associated with a poorer outcome than is seen for solitary spinal metastases. This is because surgery for paravertebral spinal lesions is more complex and requires lung resection at the same time; therefore, the risk of complications is not comparable to that for a more limited vertebrectomy procedure. Furthermore, in contrast with other large studies, we did not include lesions of the lumbar region because surgical decompression of the cauda equina by removal of lumbar metastases may be associated with a better outcome than is seen with thoracic decompression. 37 The region of the spinal column most frequently involved with metastases is the vertebral body, probably because of its large size relative to posterior elements and its high degree of vascularity. Epidural spinal cord com-pression thus usually results when tumors extend dorsally from the vertebral body into the spinal canal. 35 Typically, radiation therapy is used by oncologists as the first line of therapy for patients with metastatic spinal disease, and surgery is seldom considered for these patients before initiation of radiotherapy. The rationale for this stems from reports in which results from radiation therapy alone are compared with those from radiotherapy combined with laminectomy. Even though the surgical management of spinal metastases has evolved considerably over the years such that laminectomy alone is now infrequently proposed as a management option, results of studies based on the laminectomy procedure have led some to the incorrect Fig. 4 , who underwent vertebrectomy of T-10 and T-11 and reconstruction with methylmethacrylate via a thoracoabdominal approach. In addition to the anterior thoracolumbar plate and screws, supplemental posterior fixation (including hooks and pedicle screws) was used because the lesion was located at the thoracolumbar junction and produced severe preoperative kyphosis. Postoperatively, the patient was able to walk independently. all tumors  10  10  33  19  renal cell  2  4  8  5  breast  0  0  9  1  lung  2  0  4  3  melanoma/sarcoma  2  3  2  3 conclusion that radiation therapy is as effective as surgery. Radiation therapy alone is reported to produce neurological improvement, on average, in 44% of patients with metastatic spinal disease, 3, 8, 11, 14, 15, 27, 30 whereas laminectomy without stabilization followed by radiation therapy provides essentially the same improvement. 3, 4, 6, 8, 22, 23, 25, 26, 38 The important point to consider is that laminectomy is not the proper surgical procedure on which to base such comparisons. Not only does it provide inadequate surgical exposure, as the bulk of the tumor compressing the spinal cord usually resides not in the posterior spinal elements but in the vertebral body, but the requisite removal of sup-porting spinal elements can produce or worsen spinal instability and create deformity, which may potentially worsen a patient's neurological status.
A review of published reports on the treatment of metastatic spinal tumors by laminectomy plus stabilization demonstrated an average neurological improvement rate of 72%. 5, 7, 10, 17, 19, 28, 30, 31, 33, 34, 36 These same studies also FIG. 6 . Upper: Graph displaying the overall Kaplan-Meier survival curve for 72 patients who underwent transthoracic vertebrectomy for metastatic disease. Lower: Graph comparing survival by type of tumor for the four most commonly encountered histological types: renal cell (long-and-short-dash line), breast (unbroken line), and lung cancer (long-dash line), and melanoma or sarcoma (short-dash line). Survival curves were drawn by using the Kaplan-Meier product limit method. A shift in the number of patients with high preoperative pain scores to low postoperative pain scores signifies an improvement in the pain status for the entire population (that is, 1 + 2 + 2 + 1 + 1 + 4 = 11 patients had a preoperative pain score of 10; postoperatively, no patient had pain scores of 9 or 10). Numbers along horizontal and vertical axes refer to rating of pain (0 = no pain; 10 = worst pain). Table 2 for description of medication classification). Values within boxes indicate numbers of patients within each category. Numbers along horizontal and vertical axes refer to categories of medication. report significant pain reduction in more than of 80% of patients. Although use of laminectomy in decompressing the spinal cord is inferior to vertebrectomy because of the location of disease, addition of the stabilization procedure eliminates instability-related neurological deterioration and pain, thus resulting in a significant improvement in overall outcome. However, usually a two-to three-level laminectomy is needed for adequate decompression or transpedicular tumor removal, and spinal stabilization requires fixation of at least two spinal segments rostral and caudal to the laminectomy site (long segment fixation).
FIG. 8. Diagram indicating the relationship between preoperative and 1-month postoperative analgesic medication usage (see
The transthoracic surgical approach for vertebrectomy has a number of advantages over the posterior approach. Because the anterior approach provides the best access to the disease-containing spinal elements, it provides for maximum decompression of the spinal cord and allows the surgeon to remove the tumor in a very expeditious fashion, thus theoretically limiting blood loss. Moreover, it allows for spinal reconstruction and stabilization that results in significant pain improvement in these patients, eliminating postoperative or preexisting spinal instability. In our series, 76% of the patients showed neurological improvement (p Ͻ 0.001), and 77% of those who could not walk before undergoing surgery regained ambulatory capacity. It should be noted that the neurological improvement observed in our study was not a result of prior radiation therapy or chemotherapy because the patients who presented to us as surgical candidates were considered to have experienced treatment failure by those modalities. Whereas postoperative neurological deterioration is unusual after transthoracic vertebrectomy (1.4% in our series), it is seen in up to 20% of patients following laminectomy. 25, 34, 35 One of the authors of the present study has also described a technique for posterior vertebrectomy, reconstruction, and instrumentation that can be used for a certain subset of patients who are poor candidates for the transcavitary approach because of their more compromised overall medical condition or who have both anterior and posterior column involvement of the thoracic and lumbar spine. 1 Of 110 patients undergoing surgery for spinal metastases by posterior approaches at M. D. Anderson from 1989 to 1995, only 25 were deemed appropriate candidates for this operation. Akeyson and McCutcheon 1 considered this approach reasonable for patients who were at high risk or who had circumferential tumors, but as expected, they found a high incidence of wound infection (three [12%] of 25 patients), persistent cerebrospinal fluid leak (four [16%] of 25 patients), and graft dislodgement (four [16%] of 25 patients). Furthermore, patients who underwent this procedure had a longer average hospital stay (15 days) than those in our present (transthoracic) series (10 days) and a poorer 12-month survival rate (12% compared with 62% in this series). Thus, our current advocacy of anterior vertebrectomy does not reflect a change in philosophy at M. D. Anderson since publication of the paper by Akeyson and McCutcheon. Indeed, we believe that the transthoracic approach is the treatment of choice for spinal metastatic disease in patients who primarily have anterior column involvement and are able to tolerate a transthoracic approach.
Pain improvement has been reported for 80 to 90% of patients in most series in which vertebrectomy plus stabilization are used. 18, 20, 32, 35, 40 Table 3 ). series, and we were able to substantiate the postoperative pain improvement reported by our patients (p Ͻ 0.001 as assessed by a visual analog scale) by a significant reduction in their overall usage of analgesic medications (p Ͻ 0.001).
Despite the fact that the majority of patients who undergo a transthoracic vertebrectomy will have already received radiation treatment, the risk of infection and/or other wound-healing problems is exceedingly small in cases in which this procedure is performed (superficial wound infections in two of 72 patients in our series). On the other hand, the rate of such complications has been reported to be as high as 28% in patients who have undergone a laminectomy after radiation therapy. 35 Overall, the 30-day mortality rate for patients who have undergone laminectomy with stabilization has been reported to range from 3 to 8%, which compares favorably with that for vertebrectomy followed by stabilization, which is less than 8% (3% in our series) for the majority of series, although a few authors have reported mortality rates of 20 to 30%. 16, 20, 29, 30, 35, 36, [39] [40] [41] Table 5 summarizes the published reports of predominantly anterior vertebral body resection for spinal tumors. A comparison of our results with these previously published results is difficult because the other studies included tumors at all spinal levels and considered metastatic tumors together with primary spinal tumors and tumors extending directly from contiguous structures. The indications for the various reconstruction techniques and instrumentation used in other studies are not always clear.
Sundaresan, et al., 40 treated 101 patients for spinal tumors by the anterior approach; 68 of their patients had thoracic involvement. Because some of these 68 patients had spinal involvement by direct extension of paravertebral tumors, it is not possible to discern the exact number of spinal metastases. In a more recent article, Sundaresan and colleagues 39 report the results of a prospective study involving 54 patients with either primary or metastatic spinal tumors, 23 of which involved the thoracic spine. All of the patients had improved motor function postoperatively and pain was relieved in 90%. It is not clear how many of these patients underwent a transthoracic vertebrectomy procedure.
Similarly, good neurological recovery and pain relief were obtained by Siegal and Siegal. 35 They reported their results for vertebral body resections performed in 61 patients with malignant tumors compressing the spinal cord, 44 of which were located in the thoracic region. Eleven of these tumors were approached via a costotransversectomy and 33 via a transthoracic vertebrectomy. Hosono, et al., 20 used a ceramic prosthesis to treat 84 patients with spinal metastases; 37 of their patients had thoracic involvement. Again, improvement in motor function and pain relief were reported to be in the 80 to 90% range.
Recent changes in the health care environment have placed an emphasis on the economics of medicine and the importance of becoming cost effective. The average cost of caring for a paraplegic patient is $152,396 for the 1st year and $15,507 for each subsequent year, as reported by the National Spinal Cord Injury Statistical Center (University of Alabama, Birmingham, AL). 2 Although it is difficult to measure the true costs of these procedures, improvement in quality of life (decreased pain and improved neurological status) and a relatively short hospital stay (a mean of 10 days in our series) suggest that surgery in this situation is relatively cost effective.
Conclusions
The transthoracic approach with vertebrectomy followed by spinal stabilization for patients with metastatic spinal disease facilitates tumor excision by optimizing exposure in the diseased spinal region. In addition, spinal reconstruction can be effectively performed by reconstituting the anterior spinal column using methylmethacrylate as described. Stabilization is achieved by using a thoracic plate and screw construct that extends only one segment above and below the vertebrectomy site. With this procedure, the rates of neurological improvement and pain relief are high and the risk of wound complications is very low, a serious consideration for those who require additional radiation therapy. Overall, the rate of mortality from the procedure compares favorably to that of posterior procedures. We recommend aggressive resection of metastatic disease in the thoracic spine by a combined team of thoracic and spinal surgeons to enhance the pa- tient's quality of life and recovery of independent ambulation.
